Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Beslisboom plus CRP-POCT om antibioticagebruik bij kinderen te verlagen
jan 2026 | Antibioticaresistentie, Bacteriële infecties